Method of Producing Immortalized Primary Human Keratinocytes for HPV Investigation, Testing of Therapeutics, and Skin Graft Generation | Office of Technology Transfer, NIH

Method of Producing Immortalized Primary Human Keratinocytes for HPV Investigation, Testing of Therapeutics, and Skin Graft Generation | Office of Technology Transfer, NIH

Licensing Opportunity:

Immortalized Human Keratinocytes

An NIAID postdoctoral fellow works with a microscope. Credit: NIAID



Primary keratinocytes can be difficult to culture and are short lived, but NIAID has developed a method of immortalizing primary keratinocytes by treating cells with a defined chemical compound. These could be used for human papillomavirus (HPV) investigation, testing of therapeutics, skin graft generation and other medical applications. Read more about this exciting collaboration/licensing opportunity: https://www.ott.nih.gov/technology/e-055-2009

Follow NIAID Tech Transfer on LinkedIn.